Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01164189
Brief Title: Bevacizumab in Recurrent Grade II and III Glioma (TAVAREC)

First Submitted : July 15, 2010
First Submitted that Met QC Criteria : July 15, 2010
First Posted : July 16, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : February 27, 2019
Last Update Posted : February 28, 2019